美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=OTREXUP PFS"
符合检索条件的记录共 12 条
共 1 页，当前第 1 页
返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
OTREXUP PFS 204824 009 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 10MG/0.4ML (10MG/0.4ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 009 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 10MG/0.4ML (10MG/0.4ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 010 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 15MG/0.6ML (15MG/0.6ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 010 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 15MG/0.6ML (15MG/0.6ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 011 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 17.5MG/0.7ML (17.5MG/0.7ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 011 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 17.5MG/0.7ML (17.5MG/0.7ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 012 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 20MG/0.8ML (20MG/0.8ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 012 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 20MG/0.8ML (20MG/0.8ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 013 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 22.5MG/0.9ML (22.5MG/0.9ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 013 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 22.5MG/0.9ML (22.5MG/0.9ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 014 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 25MG/ML (25MG/ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
OTREXUP PFS 204824 014 NDA METHOTREXATE SOLUTION;SUBCUTANEOUS 25MG/ML (25MG/ML) Yes No 2013/10/11 2017/05/31 OTTER PHARMS Discontinued
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database